__timestamp | ADMA Biologics, Inc. | Viking Therapeutics, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 9517014 | 22223073 |
Thursday, January 1, 2015 | 7015946 | 6966842 |
Friday, January 1, 2016 | 7688238 | 9000499 |
Sunday, January 1, 2017 | 6229587 | 13741186 |
Monday, January 1, 2018 | 3926120 | 19040000 |
Tuesday, January 1, 2019 | 2343848 | 23559000 |
Wednesday, January 1, 2020 | 5907013 | 31931000 |
Friday, January 1, 2021 | 3646060 | 44981000 |
Saturday, January 1, 2022 | 3613764 | 54234000 |
Sunday, January 1, 2023 | 3300000 | 63806000 |
Igniting the spark of knowledge
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, ADMA Biologics, Inc. and Viking Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, ADMA Biologics, Inc. has shown a steady decline in R&D spending, with a notable 65% decrease from its peak in 2014. This trend suggests a strategic shift or potential resource reallocation within the company.
Conversely, Viking Therapeutics, Inc. has consistently increased its R&D budget, culminating in a nearly 190% rise by 2023. This robust investment underscores their aggressive pursuit of innovation and market leadership.
As the biotech landscape continues to evolve, these spending patterns offer valuable insights into each company's strategic priorities and future potential.
Comparing Innovation Spending: Merck & Co., Inc. and ADMA Biologics, Inc.
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Viking Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ADMA Biologics, Inc.
R&D Insights: How Bio-Techne Corporation and ADMA Biologics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for ADMA Biologics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development: Comparing Key Metrics for ADMA Biologics, Inc. and Viridian Therapeutics, Inc.
Viking Therapeutics, Inc. vs Amicus Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Viking Therapeutics, Inc. vs Bausch Health Companies Inc.
Research and Development Investment: Viking Therapeutics, Inc. vs Travere Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Novavax, Inc.
Viking Therapeutics, Inc. or Evotec SE: Who Invests More in Innovation?